Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7797)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 27, 2019 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fasullo M, Rau P, Liu DQ, Holzwanger E, Mathew JP, Guilarte-Walker Y, Szabo G. Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients. World J Hepatol 2019; 11(6): 522-530 [PMID: 31293720 DOI: 10.4254/wjh.v11.i6.522] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v11/i6/522.htm |
| Number | Citing Articles |
| 1 |
Marcel Yibirin, Diana De Oliveira, Roberto Valera, Andrea E Plitt, Sophia Lutgen. Adverse Effects Associated with Proton Pump Inhibitor Use. Cureus 2021; doi: 10.7759/cureus.12759
|
| 2 |
Yan Li, Wen-Cheng Liu, Bing Chang. Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases. World Journal of Gastroenterology 2022; 28(26): 3279-3281 doi: 10.3748/wjg.v28.i26.3279
Abstract(440) |
Core Tip(400) |
Full Article(HTML)(1519)
|
Full Article (PDF)-1910K(191)
|
Full Article (Word)-102K(82)
|
Audio-513K(0)
|
Peer-Review Report-185K(44)
|
Answering Reviewers-176K(49)
|
Times Cited (0)
|
Total Visits (3760)
|
Open
|
| 3 |
Yun Su, Yueqiao Chen, Jinghui Zheng, Chun Yao. Association between proton pump inhibitors and risk of hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt: a protocol for a systematic review and meta-analysis. BMJ Open 2024; 14(4): e078412 doi: 10.1136/bmjopen-2023-078412
|
| 4 |
Akira Sakamaki, Kenya Kamimura, Takeshi Yokoo, Akihiko Osaki, Seiichi Yoshikawa, Yoshihisa Arao, Toru Setsu, Hiroteru Kamimura, Nobuo Waguri, Manabu Takeuchi, Kazuhiro Funakoshi, Shuji Terai. The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors. Medicine 2021; 100(32): e26902 doi: 10.1097/MD.0000000000026902
|
| 5 |
Kunihiko Yokoyama, Akira Sakamaki, Kazuya Takahashi, Takumi Naruse, Chihiro Sato, Yuzo Kawata, Kentaro Tominaga, Hiroyuki Abe, Hiroki Sato, Atsunori Tsuchiya, Kenya Kamimura, Masaaki Takamura, Junji Yokoyama, Shuji Terai, Tatsuo Kanda. Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function. PLOS ONE 2022; 17(2): e0264459 doi: 10.1371/journal.pone.0264459
|
| 6 |
Keiji Yokoyama, Naoaki Tsuchiya, Ryo Yamauchi, Takashi Miyayama, Yotaro Uchida, Kumiko Shibata, Hiromi Fukuda, Kaoru Umeda, Kazuhide Takata, Takashi Tanaka, Shinjiro Inomata, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka, Fumihito Hirai. Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension. Internal Medicine 2020; 59(17): 2089 doi: 10.2169/internalmedicine.4628-20
|
| 7 |
Reidar Fossmark, Tom C. Martinsen, Helge L. Waldum. Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility. International Journal of Molecular Sciences 2019; 20(20): 5203 doi: 10.3390/ijms20205203
|
| 8 |
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liver. Journal of Digestive Diseases 2022; 23(4): 196 doi: 10.1111/1751-2980.13093
|
| 9 |
Daniel M. Chopyk, Arash Grakoui. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. Gastroenterology 2020; 159(3): 849 doi: 10.1053/j.gastro.2020.04.077
|
| 10 |
L. Veremme, A. Baudouin, A. Janoly-Dumenil, B. Charpiat. Thésaurus d’interventions pharmaceutiques associées aux prescriptions injustifiées d’inhibiteurs de la pompe à protons. Annales Pharmaceutiques Françaises 2023; 81(3): 552 doi: 10.1016/j.pharma.2022.11.006
|
| 11 |
Yuanqin Du, Meng Wang, Jian Xu, Ruixi Zhong, Juhong Jia, Jingjing Huang, Chun Yao, Liangjiang Huang, Guochu Huang, Xuan Ke, Han Wang, Lei Fu. Investigation of therapeutic effects of rhubarb decoction retention enema on minimal hepatic encephalopathy in rats based on 16S rDNA gene sequencing and bile acid metabolomics. Journal of Pharmaceutical and Biomedical Analysis 2023; 230: 115392 doi: 10.1016/j.jpba.2023.115392
|
| 12 |
Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, Yasuhiko Sawada, Masanori Furukawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Hiroshi Fukui, Hitoshi Yoshiji. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. International Journal of Molecular Sciences 2021; 22(13): 6921 doi: 10.3390/ijms22136921
|
| 13 |
Chathur Acharya, Jasmohan S. Bajaj. Response to Labenz and Labenz. American Journal of Gastroenterology 2021; 116(11): 2304 doi: 10.14309/ajg.0000000000001406
|
| 14 |
Anam Fatima, Faridullah Shah, Hareema Saeed Khan, Kashif Rauf, Asif Jalil, Muhammad Saleem Akhter. Association Of Electroencephalogram Patterns With Ammonia Levels In Hepatic Encephalopathy Patients. Journal of Rawalpindi Medical College 2023; 27(3) doi: 10.37939/jrmc.v27i3.2041
|
| 15 |
Moloud Balafar, Morteza Ghojazadeh, Kavous Shahsavarinia, Zahra Parsian, Saba Hamedani, Hassan Soleimanpour. Association Between Proton Pump Inhibitor Use and Spontaneous Bacterial Peritonitis or Hepatic Encephalopathy in Cirrhotic Patients: A Systematic Review and Meta-analysis. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-132642
|
| 16 |
Lin Shi, Dan Zhang. Proton Pump Inhibitor Use Before ICU Admission Is Not Associated With Mortality of Critically Ill Patients. The Journal of Clinical Pharmacology 2020; 60(7): 860 doi: 10.1002/jcph.1585
|
| 17 |
Sarah Henkel, Carol Vetterly, Robert Squires, Patrick McKiernan, James Squires. Pharmacological management of portal hypertension and its complications in children: lessons from adults and opportunities for the future. Expert Opinion on Pharmacotherapy 2021; 22(3): 291 doi: 10.1080/14656566.2020.1825685
|